Medicine
Effect of Danggui Buxue Medicinal Diet on cancer-related fatigue in anemic colon cancer patients undergoing chemotherapy: A randomized controlled trial (CONSORT-compliant)
By Wang L, Yang L, Wang L and 7 others.
Abstract
Background
Cancer-related fatigue (CRF) is one of the most common and distressing symptoms experienced by patients undergoing chemotherapy, and no gold standard for the treatment of CRF has been established. This study aimed to evaluate the effects of the Danggui Buxue Medicinal Diet on CRF in patients with chemotherapy-induced anemia following colon cancer surgery.
Methods
A total of 96 patients admitted to the intestinal surgery ward and daytime chemotherapy ward of a tertiary hospital from May 2021 to December 2022 who met the inclusion criteria were selected and randomly divided into 2 groups: 48 patients in the control group and 48 in the experimental group. The control group received standard treatment and nursing care for postoperative chemotherapy for colon cancer, while the experimental group followed the control group's regimen and additionally received the Danggui Buxue Medicinal Diet for 21 consecutive days. Fatigue levels, blood counts, and inflammatory factors were compared before and after the intervention in both groups.



